KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Total Liabilities (2016 - 2025)

CareDx (CDNA) has disclosed Total Liabilities for 13 consecutive years, with $110.1 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 2.21% to $110.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $110.1 million through Dec 2025, down 2.21% year-over-year, with the annual reading at $110.1 million for FY2025, 2.21% down from the prior year.
  • Total Liabilities hit $110.1 million in Q4 2025 for CareDx, down from $121.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $205.5 million in Q4 2023 to a low of $69.7 million in Q1 2021.
  • Historically, Total Liabilities has averaged $122.5 million across 5 years, with a median of $109.9 million in 2023.
  • Biggest YoY gain for Total Liabilities was 90.33% in 2024; the steepest drop was 45.2% in 2024.
  • Year by year, Total Liabilities stood at $100.7 million in 2021, then rose by 11.25% to $112.1 million in 2022, then soared by 83.35% to $205.5 million in 2023, then crashed by 45.2% to $112.6 million in 2024, then fell by 2.21% to $110.1 million in 2025.
  • Business Quant data shows Total Liabilities for CDNA at $110.1 million in Q4 2025, $121.2 million in Q3 2025, and $116.9 million in Q2 2025.